Abstract:A new methanolato-bridged dinuclear oxovanadium(V) complex [VO(L)(OMe)]2 (I) derived from N'-(2-hydroxy-5-methylbenzylidene)-2-methylbenzohydrazide (H2L) and a new mononuclear oxovanadium(V) complex [VO(L')(OMe)(MeOH)] (II) derived from 3-chloro-N'-(2-hydroxy-3-methylbenzylidene)benzohydrazide (H2L') were prepared and characterized by infrared spectra and single crystal X-ray determination (CIF files CCDC nos. 974793 (I) and 974792 (II)). Complex I crystallizes as triclinic space group P \(\overline 1 \) with unit cell dimensions a = 8.5063(4), b = 9.5367(4), c = 11.2445(5) Å, α = 71.740(1)°, β = 72.341(1)°, γ = 74.509(1)°, V = 810.37(6) Å3, Z = 1, R 1 = 0.0527, wR 2 = 0.1316, S = 0.969. The complex possesses a crystallographic inversion center symmetry between two V atoms. Complex II crystallizes as triclinic space group P \(\overline 1 \) with unit cell dimensions a = 7.4257(3), b = 9.9475(4), c = 13.1021(5) Å, α = 71.954(1)°, β = 85.657(1)°, γ = 84.127(1)°, V = 914.38(6) Å3, Z = 2, R 1 = 0.0365, wR 2 = 0.0957, S = 1.039. The tridentate aroylhydrazone ligands coordinate to the V center through azomethine nitrogen, phenolate oxygen, and enolate oxygen. The V atoms in the complexes are in octahedral coordination. Crystal structures of the complexes are stabilized by hydrogen bonds and π···π interactions.

Synthesis, Crystal Structure, and Urease Inhibition of [N′-(3,5-dibromo-2-hydroxybenzylidene)isonicotinohydrazido]-(benzohydroxamato)oxovanadium(v)

Syntheses, Characterization, and Urease Inhibition of Oxidovanadium(V) Complexes with Tridentate Hydrazone and Bidentate Benzohydroxamate Ligands

Urease Inhibition of Oxovanadium(v) Complexes with Hydrazone and Hydroxamate Ligands

Synthesis, Crystal Structures, and Biological Activity of Oxovanadium(V) Complexes with Similar Tridentate Hydrazone Ligands

Synthesis and Structural Characterization of Oxovanadium(v) Complexes with Mixed Tridentate Benzohydrazone and Bidentate No Ligands

Synthesis, Characterization, and Crystal Structure of [N′-(3-ethoxy-2-hydroxybenzylidene)-4-fluorobenzohydrazido](quinolin-8-olato)oxovanadium(v)

Synthesis, Characterization, and X-Ray Crystal Structures of Oxovanadium(V) Complexes with Hydrazone and 8-Hydroxyquinoline Ligands

Synthesis, Characterization and Crystal Structures of Oxovanadium(v) Complexes Derived from Similar Aroylhydrazone Ligands

Two Isomeric Structures of Oxovanadium(v) Complexes with Hydrazone and 8-Hydroxyquinoline Ligands

Characterization and X-Ray Structures of Oxovanadium(V) Complexes Derived from Hydrazone Ligands

Synthesis, Characterization and Crystal Structure of Oxovanadium(V) Complex Derived from 2-Bromo-4-chloro-6-((2-(ethylamino)ethylimino)methyl)phenol

Syntheses, Characterization, and Structures of Vanadium(v) Complexes with Similar Tridentate Hydrazone and Bidentate Benzohydroxamate Ligands

Synthesis, Characterization, and Crystal Structures of Oxidovanadium(V) Complexes Derived from Similar Hydrazone and Benzohydroxamate Mixed Ligands

Synthesis and X-Ray Structures of Di- and Mono-Nuclear Oxovanadium(V) Complexes Derived from Aroylhydrazones

Synthesis and Crystal Structure of an Mn(II) Complex with Benzoylacetone

Characterization and Crystal Structures of Oxovanadium(V) Complexes Derived from N′ -(2-Hydroxybenzylidene)pivalohydrazide

Synthesis, Characterization, and Crystal Structures of New Oxovanadium(V) Complexes with Mixed Nicotinohydrazone and 8-Hydroxyquinoline Ligands

Diaqua(2,2′-diamino-4,4′-bi-1,3-thiazole)oxosulfatovanadium(IV) Tetrahydrate

Synthesis, X-Ray Crystal Structures and Catalytic Epoxidation of Oxidovanadium(V) Complexes Derived from N'-(5-Chloro-2-Hydroxybenzylidene)-3-Methylbenzohydrazide

Synthesis, Crystal Structure, and DNA Interaction of an Oxovanadium(iv) Complex Containing L-valine Schiff Base and 1,10-Phenanthroline

Synthesis, Structure and Properties of (H 2 NCH 2 CH 2 NH 3 ) 3 {(VO) 6 [B 10 O 16 (OH) 6 ] 2 } · 11H 2 O